APA (7th ed.) Citation

Trøseid, M., Arribas, J. R., Assoumou, L., Holten, A. R., Poissy, J., Terzić, V., . . . group, E. S. s. (2023). Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct). Critical Care, 27(1), 1. https://doi.org/10.1186/s13054-022-04205-8

Chicago Style (17th ed.) Citation

Trøseid, Marius, et al. "Efficacy and Safety of Baricitinib in Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct)." Critical Care 27, no. 1 (2023): 1. https://doi.org/10.1186/s13054-022-04205-8.

MLA (9th ed.) Citation

Trøseid, Marius, et al. "Efficacy and Safety of Baricitinib in Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct)." Critical Care, vol. 27, no. 1, 2023, p. 1, https://doi.org/10.1186/s13054-022-04205-8.